{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:42:42Z","timestamp":1769629362086,"version":"3.49.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/aco.0b013e32833c3473","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T15:25:24Z","timestamp":1276269924000},"page":"616-622","source":"Crossref","is-referenced-by-count":45,"title":["Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects"],"prefix":"10.1097","volume":"23","author":[{"given":"Peter","family":"Holzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210129","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(09)60139-2","article-title":"Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus","volume":"373","author":"Becker","year":"2009","journal-title":"Lancet"},{"key":"R2-15-20210129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000165778","article-title":"Meeting the challenges of opioid-induced constipation in chronic pain management: a novel approach","volume":"83","author":"Reimer","year":"2009","journal-title":"Pharmacology"},{"key":"R3-15-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0165-6147(86)90274-9","article-title":"Central opioid receptor involvement in gastrointestinal motility","volume":"7","author":"Porreca","year":"1986","journal-title":"Trends Pharmacol Sci"},{"key":"R4-15-20210129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pharmthera.2007.09.007","article-title":"The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor","volume":"117","author":"DeHaven-Hudkins","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"R5-15-20210129","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1089\/jpm.2008.9839.supp","article-title":"Palliative care and pain: new strategies for managing opioid bowel dysfunction","volume":"11","author":"Thomas","year":"2008","journal-title":"J Palliat Med"},{"key":"R6-15-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2009.03.012","article-title":"Opioid receptors in the gastrointestinal tract","volume":"155","author":"Holzer","year":"2009","journal-title":"Regul Pept"},{"key":"R7-15-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0163-7258(95)02053-5","article-title":"Insights into opioid action in the intestinal tract","volume":"69","author":"De Luca","year":"1996","journal-title":"Pharmacol Ther"},{"key":"R8-15-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/13543784.16.2.181","article-title":"Treatment of opioid-induced gut dysfunction","volume":"16","author":"Holzer","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"R9-15-20210129","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1742-1241.2007.01415.x","article-title":"Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden","volume":"61","author":"Panchal","year":"2007","journal-title":"Int J Clin Pract"},{"key":"R10-15-20210129","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10354-008-0589-9","article-title":"Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment","volume":"158","author":"Osterbrink","year":"2008","journal-title":"Wien Med Wochenschr"},{"key":"R11-15-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-3565(25)11008-2","article-title":"Peptide opioid antagonist separates peripheral and central opioid antitransit effects","volume":"243","author":"Shook","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-15-20210129","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2036.2008.03689.x","article-title":"Gastrointestinal side effects in chronic opioid users: results from a population-based survey","volume":"27","author":"Cook","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-15-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5055\/jom.2009.0014","article-title":"Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey","volume":"5","author":"Bell","year":"2009","journal-title":"J Opioid Manag"},{"key":"R14-15-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4637.2008.00495.x","article-title":"The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)","volume":"10","author":"Bell","year":"2009","journal-title":"Pain Med"},{"key":"R15-15-20210129","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ajg.2009.71","article-title":"Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study","volume":"104","author":"Choung","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R16-15-20210129","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1185\/03007991003787318","article-title":"Innovative pain therapy with a fixed combination of prolonged-release oxycodone\/naloxone: a large observational study under conditions of daily practice.","volume":"26","author":"Schutter","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"R17-15-20210129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2982.2009.01458.x","article-title":"Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic noncancer pain","volume":"22","author":"Tuteja","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"R19-15-20210129","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gtc.2009.06.001","article-title":"Chronic constipation in the elderly","volume":"38","author":"Bouras","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"key":"R20-15-20210129","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10147-008-0829-4","article-title":"Feasibility study of direct fentanyl patch introduction without prior opioid titration","volume":"14","author":"Matsui","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"R21-15-20210129","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"R22-15-20210129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3111\/13696990903430481","article-title":"Validation of the bowel function index to detect clinically meaningful changes in opioid-induced constipation","volume":"12","author":"Rentz","year":"2009","journal-title":"J Med Econ"},{"key":"R23-15-20210129","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4065\/83.10.1116","article-title":"Development of peripheral opioid antagonists' new insights into opioid effects","volume":"83","author":"Moss","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R24-15-20210129","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2008.169250","article-title":"Neuroimmune mechanisms in postoperative ileus","volume":"58","author":"Boeckxstaens","year":"2009","journal-title":"Gut"},{"key":"R25-15-20210129","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1213\/ane.0b013e31819e0d3a","article-title":"Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability","volume":"108","author":"Viscusi","year":"2009","journal-title":"Anesth Analg"},{"key":"R26-15-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2982.2007.01078.x","article-title":"Alvimopan and COX-2 inhibition reverse opioid and inflammatory components of postoperative ileus","volume":"20","author":"Schmidt","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"R27-15-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.18553\/jmcp.2009.15.6.485","article-title":"Economic burden of postoperative ileus associated with colectomy in the United States","volume":"15","author":"Iyer","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"R28-15-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(99)00185-2","article-title":"Oral naloxone reverses opioid-associated constipation","volume":"84","author":"Meissner","year":"2000","journal-title":"Pain"},{"key":"R29-15-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5055\/jom.2009.0015","article-title":"Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management","volume":"5","author":"Holzer","year":"2009","journal-title":"J Opioid Manag"},{"key":"R30-15-20210129","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.clinthera.2008.11.008","article-title":"Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist\/antagonist prolonged-release combination in healthy adult volunteers","volume":"30","author":"Smith","year":"2008","journal-title":"Clin Ther"},{"key":"R31-15-20210129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpain.2008.06.012","article-title":"A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation","volume":"13","author":"Meissner","year":"2009","journal-title":"Eur J Pain"},{"key":"R32-15-20210129","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1742-1241.2008.01820.x","article-title":"Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain","volume":"62","author":"Nadstawek","year":"2008","journal-title":"Int J Clin Pract"},{"key":"R33-15-20210129","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jpain.2008.06.014","article-title":"Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain","volume":"9","author":"Vondrackova","year":"2008","journal-title":"J Pain"},{"key":"R34-15-20210129","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1185\/03007990802584454","article-title":"Fixed-ratio combination oxycodone\/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain","volume":"24","author":"Simpson","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"R35-15-20210129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/14656560902796798","article-title":"Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe nonmalignant chronic pain: a randomised controlled trial","volume":"10","author":"L\u00f6wenstein","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R36-15-20210129","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1742-1241.2010.02360.x","article-title":"Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of noncancer chronic pain","volume":"64","author":"Sandner-Kiesling","year":"2010","journal-title":"Int J Clin Pract"},{"key":"R37-15-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/14656560903483222","article-title":"Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain","volume":"11","author":"Clemens","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"R38-15-20210129","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/14750708.4.5.653","article-title":"Alvimopan: a peripheral acting mu-opioid-receptor antagonist used for the treatment of postoperative ileus","volume":"4","author":"Balsama","year":"2007","journal-title":"Therapy"},{"key":"R39-15-20210129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1358\/dot.2007.43.9.1086176","article-title":"Alvimopan: a peripherally acting mu-opioid receptor antagonist","volume":"43","author":"Leslie","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"R40-15-20210129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/sj.clpt.6100292","article-title":"Pharmacokinetics of alvimopan and its metabolite in healthy volunteers and patients in postoperative ileus trials","volume":"83","author":"Foss","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R41-15-20210129","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/0091270009347474","article-title":"The effects of a short course of antibiotics on alvimopan and metabolite pharmacokinetics","volume":"50","author":"Schmith","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"R42-15-20210129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2147\/TCRM.S3147","article-title":"Management of postoperative ileus: focus on alvimopan","volume":"4","author":"Marderstein","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"R43-15-20210129","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pain.2007.11.008","article-title":"Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic noncancer pain","volume":"137","author":"Webster","year":"2008","journal-title":"Pain"},{"key":"R44-15-20210129","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2146\/ajhp080329","article-title":"Economic analysis of alvimopan in North American phase III efficacy trials","volume":"66","author":"Bell","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"R45-15-20210129","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2146\/ajhp080445","article-title":"Alvimopan for postoperative ileus","volume":"66","author":"Bream-Rouwenhorst","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"R46-15-20210129","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.sla.0000141158.27977.66","article-title":"Alvimopan, a novel, peripherally acting mu-opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus","volume":"240","author":"Wolff","year":"2004","journal-title":"Ann Surg"},{"key":"R47-15-20210129","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s10350-005-0035-7","article-title":"Phase III trial of alvimopan, a novel, peripherally acting, mu-opioid antagonist, for postoperative ileus after major abdominal surgery","volume":"48","author":"Delaney","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"R48-15-20210129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajog.2006.01.039","article-title":"A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy","volume":"195","author":"Herzog","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R49-15-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00464-005-0104-y","article-title":"Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study","volume":"20","author":"Viscusi","year":"2006","journal-title":"Surg Endosc"},{"key":"R50-15-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2036.2008.03696.x","article-title":"Clinical trial: alvimopan for the management of postoperative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study","volume":"28","author":"B\u00fcchler","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R51-15-20210129","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archsurg.143.11.1098","article-title":"Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway","volume":"143","author":"Ludwig","year":"2008","journal-title":"Arch Surg"},{"key":"R52-15-20210129","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.surg.2007.07.004","article-title":"Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use","volume":"142","author":"Senagore","year":"2007","journal-title":"Surgery"},{"key":"R53-15-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2036.2006.03150.x","article-title":"Meta-analysis: alvimopan vs. placebo in the treatment of postoperative ileus","volume":"25","author":"Tan","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R54-15-20210129","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1526-4637.2007.00335.x","article-title":"Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"McNicol","year":"2008","journal-title":"Pain Med"},{"key":"R55-15-20210129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpain.2004.12.001","article-title":"Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction:a 21-day treatment-randomized clinical trial","volume":"6","author":"Paulson","year":"2005","journal-title":"J Pain"},{"key":"R56-15-20210129","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/13543784.15.5.541","article-title":"Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side-effects","volume":"15","author":"Yuan","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"R57-15-20210129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/14750708.5.4.531","article-title":"Methylnaltrexone for the management of unwanted peripheral opioid effects","volume":"5","author":"Holzer","year":"2008","journal-title":"Therapy"},{"key":"R58-15-20210129","first-page":"90","article-title":"Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side-effects","volume":"9","author":"Reichle","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"R59-15-20210129","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/dmd.109.031179","article-title":"Metabolism of intravenous methylnaltrexone in mice, rats, dogs, and humans","volume":"38","author":"Chandrasekaran","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"R60-15-20210129","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/dmd.110.032169","article-title":"In-vitro metabolism and identification of human enzymes involved in the metabolism of methylnaltrexone","volume":"38","author":"Tong","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"R61-15-20210129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jpainsymman.2007.12.005","article-title":"Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study","volume":"35","author":"Portenoy","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"R62-15-20210129","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N Engl J Med"},{"key":"R63-15-20210129","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jpainsymman.2009.02.234","article-title":"Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness","volume":"38","author":"Chamberlain","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"R64-15-20210129","first-page":"39","article-title":"Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients","volume":"7","author":"Slatkin","year":"2009","journal-title":"J Support Oncol"},{"key":"R65-15-20210129","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2036.2010.04244.x","article-title":"Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness: a cost-effectiveness analysis","volume":"31","author":"Earnshaw","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R66-15-20210129","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/13543784.17.9.1365","article-title":"Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus","volume":"17","author":"Kraft","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"R67-15-20210129","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4140\/TCP.n.2009.210","article-title":"Methylnaltrexone methobromide: the first peripherally active, centrally inactive opioid receptor-antagonist","volume":"24","author":"Guay","year":"2009","journal-title":"Consult Pharm"},{"key":"R68-15-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/TCRM.S4301","article-title":"Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide","volume":"6","author":"Clemens","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"R69-15-20210129","first-page":"44","article-title":"Alvimopan (entereg) for the management of postoperative ileus in patients undergoing bowel resection","volume":"35","author":"Kraft","year":"2010","journal-title":"P T"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0b013e32833c3473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:37:06Z","timestamp":1740177426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201010000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0b013e32833c3473","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}